Latest TB Stories
TBA-354 is the first potential tuberculosis drug to advance to Phase 1 trial in six years NEW YORK, Feb.
- Assign-bTB Designed to Differentiate TB-Infected Animals from Vaccinated Ones PALMERSTON NORTH, New Zealand, Feb.
HILDEN, Germany and BEIJING, February 11, 2015 /PRNewswire/ -- - China's first population-based study of latent TB infection, published in The
NEW YORK, Jan.
Drug for treating diabetes can double up as adjunct treatment for tuberculosis SINGAPORE, Dec 17, 2014 - (ACN Newswire)
Memorandum of Understanding Signed to Address the Global Health Threat of Antibiotic-Resistant Bacteria NEW BRUNSWICK, N.J., Dec.
Sophisticated lung imaging can reveal whether or not a treatment drug is able to clear tuberculosis (TB) lung infection in human and macaque parallel studies, according to University of Pittsburgh
Sanofi Commitment to Research and Develop TB Treatments, Diagnostics and Vaccines Spans More than 50 Years BRIDGEWATER, N.J., Dec.
Using freeze-drying process to overcome cold-chain transportation issues SEATTLE, Nov.
RARITAN, N.J., Nov.
- A political dynamiter.